These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study). Rabe E; Schliephake D; Otto J; Breu FX; Pannier F Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861 [TBL] [Abstract][Full Text] [Related]
23. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial. Mishra S; Sahoo AK; Elamurugan TP; Jagdish S Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957 [TBL] [Abstract][Full Text] [Related]
24. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971 [TBL] [Abstract][Full Text] [Related]
26. Ultrasound-guided sclerotherapy of the great saphenous vein with 1% vs. 3% polidocanol foam: a multicentre double-blind randomised trial with 3-year follow-up. Blaise S; Bosson JL; Diamand JM Eur J Vasc Endovasc Surg; 2010 Jun; 39(6):779-86. PubMed ID: 20206556 [TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial. Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099 [TBL] [Abstract][Full Text] [Related]
28. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial. Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758 [TBL] [Abstract][Full Text] [Related]
29. Polidocanol (aethoxysklerol) for sclerotherapy of superficial venules and telangiectasias. Goldman PM J Dermatol Surg Oncol; 1989 Feb; 15(2):204-9. PubMed ID: 2644330 [TBL] [Abstract][Full Text] [Related]
30. Treatment of lower extremity telangiectasias in women by foam sclerotherapy vs. Nd:YAG laser: a prospective, comparative, randomized, open-label trial. Parlar B; Blazek C; Cazzaniga S; Naldi L; Kloetgen HW; Borradori L; Buettiker U J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):549-54. PubMed ID: 25069999 [TBL] [Abstract][Full Text] [Related]
31. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review. Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455 [TBL] [Abstract][Full Text] [Related]
32. Telangiectasias resistant to sclerotherapy are commonly connected to a perforating vessel. Schuller-Petrović S; Pavlović MD; Schuller S; Schuller-Lukic B; Adamic M Phlebology; 2013 Sep; 28(6):320-3. PubMed ID: 22865418 [TBL] [Abstract][Full Text] [Related]
33. Sclerotherapy in tumescent anesthesia of reticular veins and telangiectasias. Ramelet AA Dermatol Surg; 2012 May; 38(5):748-51. PubMed ID: 22268802 [TBL] [Abstract][Full Text] [Related]
34. Craniofacial venous malformations treated by percutaneous sclerotherapy using polidocanol: a single-center experience. Grieb D; Meila D; Greling B; Jacobs C; Hechtner M; Schlunz-Hendann M; Brassel F Acta Radiol; 2019 May; 60(5):593-601. PubMed ID: 30111191 [TBL] [Abstract][Full Text] [Related]
35. The efficacy of polidocanol sclerotherapy in mucocele of the minor salivary gland. Liu JL; Zhang AQ; Jiang LC; Li KY; Liu FZ; Yuan DY; Xu K; Fan QC; Liu XB; Zou B; Meng Z; Feng Y; Zhang B J Oral Pathol Med; 2018 Oct; 47(9):895-899. PubMed ID: 29998466 [TBL] [Abstract][Full Text] [Related]
36. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins. Rao J; Wildemore JK; Goldman MP Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411 [TBL] [Abstract][Full Text] [Related]
37. Treatment of varicose and telangiectatic leg veins: double-blind prospective comparative trial between aethoxyskerol and sotradecol. Goldman MP Dermatol Surg; 2002 Jan; 28(1):52-5. PubMed ID: 11991271 [TBL] [Abstract][Full Text] [Related]
38. A double-blind, randomized study comparing pure chromated glycerin with chromated glycerin with 1% lidocaine and epinephrine for sclerotherapy of telangiectasias and reticular veins. Kern P; Ramelet AA; Wutschert R; Mazzolai L Dermatol Surg; 2011 Nov; 37(11):1590-4. PubMed ID: 21883648 [TBL] [Abstract][Full Text] [Related]
39. Percutaneous sclerotherapy with polidocanol under the guidance of ultrasound for venous malformations in children - A retrospective cohort study from a single tertiary medical center. Hou F; Chen J; Xia M; Ding K; Zeng Q; Liu W Medicine (Baltimore); 2020 Feb; 99(9):e18839. PubMed ID: 32118707 [TBL] [Abstract][Full Text] [Related]
40. Successful Endoscopic Sclerotherapy Using Polidocanol for Small Bowel Hemangioma. Aoyama T; Fukumoto A; Shigita K; Asayama N; Mukai S; Nagata S Intern Med; 2020 Jul; 59(14):1727-1730. PubMed ID: 32238724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]